Mukherjee, P., Ginardi, A.R., Madsen, C.S., Sterner, C.J., Adriance, M.C., and Gendler, S.J. (2000) Mice with spontaneous pancreatic cancer naturally develop MUC1-specific CTLs that eradicate tumors when adoptively transferred. Journal of Immunology 165: 3451-3460.
Mukherjee, P., Ginardi, A.R., Tinder, T.L., Sterner, C.J. and Gendler S.J. (2000) MUC1-specific CTLs eradicate tumors when adoptively transferred in vivo. Clinical Cancer Research 7: 848 – 855.
Gendler, S.J., and Mukherjee, P. (2001) Spontaneous Adenocarcinoma Mouse Models for Immunotherapy. Trends in Molecular Medicine, 7: 471 – 475.
McConnell, E.J., Pathangey, L.B., Madsen, C.S., Gendler, S.J., and Mukherjee, P. (2002) DC-Tumor Cell Fusion and SEB Treatment in a Pancreatic Tumor Model. J. Surgical Research 107: 196 – 202.
Mukherjee, P., Madsen, C.S., Ginardi, A.R., Tinder, T.L., Jacobs, F., Parker, J., Agrawal, B., Longenecker, B.M. and Gendler, S.J. (2003) MUC1-specific immunotherapy in a mouse model of spontaneous breast cancer. J. Immunother 26:47-62.
Xia J, Tanaka Y, Koido S, Liu C, Mukherjee P, Gendler SJ and Gong J (2003) Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells. J Immunol 170:1980-1986.
Mukherjee P, Ginardi AR, Madsen CS, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, and Gendler SJ (2003) MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. Glycoconjugate J 18:931-942.
Chen, D. Xia, J., Tanaka, Y., Chen, H. Koido, S., Werner, O., Mukherjee, P., Gendler, S.J., Kufe, D. and Gong, J. (2003) Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology 109:300-307.
Pockaj, B.A., Basu, G.D., Pathangey, L.B., Gray, R.J., Hernandez, J.L., Gendler, S.J. and Mukherjee, P. (2004) Reduced T cell function is related to COX-2 over-expression and PGE2 secretion in patients with breast cancer. Ann Surg Oncol 11:328-339.
Mukherjee, P., Tinder, T.L., Basu, G.D., Pathangey, L.B., Chen, L. and Gendler, S.J. (2004) Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model. Breast Disease 20:53-63.
Gargi D. Basu, Latha B. Pathangey, Teresa L. Tinder, Michelle LaGioia, Sandra J. Gendler, and Pinku Mukherjee (2004) COX-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer. Mol Cancer Res 2:632-642 (Cover) (American Association for Cancer Research Press Release).
- Mukherjee, T. L. Tinder, G. D. Basu, and S. J. Gendler (2005) MUC1 modulates human T lymphoma cell proliferation. J Leukoc Biol 77:90-99.
Gargi D. Basu, Latha B. Pathangey, Sandra J. Gendler, and Pinku Mukherjee (2005) The cyclooxygenase-2 inhibitor, celecoxib, inhibits growth and micro-vascular channels in human breast cancer cells. Breast Cancer Research, 7:422-435 (Breast Cancer Net News Release).
Theodore H. Lindsay, Beth M. Jonas, Molly A. Sevcik, Kazufumi Kubota, Kyle G. Halvorson, Joseph R. Ghilardi, Micheal A. Kuskowski, Edward B. Stelow, Pinku Mukherjee, Sandra J. Gendler, Gilbert Y. Wong, Patrick W. Mantyh (2005) Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression. Pain, 119:233-246 (Cover).
Gargi D. Basu, Teresa L. Tinder, Bradley, J.M., Tu, T., Hattrup, C.L., Pockaj, B.A., and Pinku Mukherjee. (2006). Cyclooxygenase-2 Inhibitor Enhances the Efficacy of a Breast Cancer Vaccine. Journal of Immunology, 177:2391-2402.
Thompson, E.J., Shanmugam, K., Hattrup, C.L., Kotlarczyk, K.L., Gutierrez, A., Bradley, J.M., Mukherjee, P. and Gendler, S.J. (2006). Tyrosines in the MUC1 cytoplasmic tail modulate transcription via the ERK1/2 and NF-κB pathways. Molecular Cancer Research, 4:489-497.
Nate Koewler, Molly A. Sevcik, Beth M. Jonas, Theodore H. Lindsay, Kyle G. Halvorson, Joseph R. Ghilardi, Pinku Mukherjee, and Patrick W. Mantyh (2006). Endogenous Opiods inhibit early stage pancreatic pain in a mouse model of pancreatic cancer. Gastroenterology, 131: 900-910.